CAS 1225208-94-5
:Pyrrolidinium, 1-[[(6R,7R)-7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-[(1-carboxy-1-methylethoxy)imino]acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-1-[2-[(2-chloro-3,4-dihydroxybenzoyl)amino]ethyl]-, inner salt
Description:
Pyrrolidinium, 1-[[(6R,7R)-7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-[(1-carboxy-1-methylethoxy)imino]acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-1-[2-[(2-chloro-3,4-dihydroxybenzoyl)amino]ethyl]-, inner salt, is a complex organic compound characterized by its intricate molecular structure, which includes multiple functional groups such as amino, carboxyl, and thiazole moieties. This compound is likely to exhibit properties typical of pyrrolidinium salts, including solubility in polar solvents and potential biological activity due to its structural components. The presence of thiazole and bicyclic structures suggests possible interactions with biological targets, making it of interest in medicinal chemistry. Additionally, the inner salt formation indicates a stable ionic structure, which may influence its reactivity and stability under various conditions. Overall, this compound's unique characteristics may contribute to its utility in pharmaceutical applications or as a research tool in biochemical studies.
Formula:C30H34ClN7O10S2
InChI:InChI=1S/C30H34ClN7O10S2/c1-30(2,28(46)47)48-36-19(16-13-50-29(32)34-16)24(42)35-20-25(43)37-21(27(44)45)14(12-49-26(20)37)11-38(8-3-4-9-38)10-7-33-23(41)15-5-6-17(39)22(40)18(15)31/h5-6,13,20,26H,3-4,7-12H2,1-2H3,(H7-,32,33,34,35,36,39,40,41,42,44,45,46,47)/t20-,26-/m1/s1
InChI key:InChIKey=DBPPRLRVDVJOCL-FQRUVTKNSA-N
SMILES:C([O-])(=O)C=1N2[C@@]([C@H](NC(/C(=N\OC(C(O)=O)(C)C)/C3=CSC(N)=N3)=O)C2=O)(SCC1C[N+]4(CCNC(=O)C5=C(Cl)C(O)=C(O)C=C5)CCCC4)[H]
Synonyms:- Cefiderocol
- Pyrrolidinium, 1-[[(6R,7R)-7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-[(1-carboxy-1-methylethoxy)imino]acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-1-[2-[(2-chloro-3,4-dihydroxybenzoyl)amino]ethyl]-, inner salt
- GSK 2696266
- S 649266
- Fetroja
- (6R,7R)-7-((Z)-2-(2-Aminothiazol-4-yl)-2-(((2-carboxypropan-2-yl)oxy)imino)acetamido)-3-((1-(2-(2-chloro-3,4-dihydroxybenzamido)ethyl)pyrrolidin-1-ium-1-yl)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 8 products.
1-{[(6R,7R)-7-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(1-carboxy-1-methylethoxy)imino]acetamido]-2-carboxylato-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl}-1-{2-[(2-chloro-3,4-dihydroxyphenyl)formamido]ethyl}pyrrolidin-1-ium
CAS:Formula:C30H34ClN7O10S2Purity:95%Color and Shape:SolidMolecular weight:752.2149Cefiderocol
CAS:<p>Cefiderocol (S-649266) is a new type of siderophore-cephalosporin conjugate with antibacterial activity, inhibiting aerobic gram-negative bacteria.</p>Formula:C30H34ClN7O10S2Purity:98.46%Color and Shape:SolidMolecular weight:752.22Cefiderocol
CAS:Formula:C30H34ClN7O10S2Purity:≥ 95.0%Color and Shape:White to off-white powderMolecular weight:752.21Cefiderocol
CAS:<p>Cefiderocol is a siderophore cephalosporin antibiotic with action on bacterial cell wall synthesis, particularly targeting multidrug-resistant gram-negative bacteria and is used for treating complicated urinary tract infections and hospital-acquired pneumonia.</p>Formula:C30H34CLN7O10S2Purity:Min. 95%Color and Shape:PowderMolecular weight:752.2 g/mol








